Hyperaldosteronism
MONDO:0003009Overproduction of aldosterone by the adrenal glands, which may lead to hypokalemia and/or hypernatremia.
Also known as: primary hyperaldosteronism
57 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Alcohol injection into adrenal tumors may offer surgery-free blood pressure control
Disease control Not yet recruitingThis study tests a procedure that uses a thin needle guided by an endoscope to inject alcohol into a benign adrenal tumor that produces too much aldosterone, a hormone that raises blood pressure. The goal is to destroy the tumor without surgery. The trial enrolls 30 adults with l…
Phase: NA • Sponsor: Chongqing Medical University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Blood pressure breakthrough? Renin-Guided therapy may offer smarter First-Line treatment
Disease control Not yet recruitingThis study explores whether measuring a hormone called renin can help doctors choose the best first medication for people with early-stage high blood pressure. Adults with low renin levels are randomly assigned to receive either spironolactone or a standard blood pressure drug fo…
Phase: PHASE4 • Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Tighter blood pressure target may slash heart risks in hormone disorder
Disease control Not yet recruitingThis trial compares two blood pressure targets in people with primary aldosteronism, a hormonal condition that causes high blood pressure. One group aims for a systolic pressure below 120 mmHg (intensive), the other between 120 and 140 mmHg (standard). Over 6 to 10 years, researc…
Phase: NA • Sponsor: Chongqing Medical University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug SAL0140 aims to tame Hormone-Driven high blood pressure
Disease control Not yet recruitingThis phase 2 trial tests a new drug called SAL0140 in 50 adults with primary aldosteronism, a condition where the adrenal glands make too much aldosterone, causing high blood pressure. Participants will receive either SAL0140 or a placebo for 12 weeks to see if it safely lowers b…
Phase: PHASE2 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a month of hydrocortisone protect kidneys after adrenal surgery?
Disease control Not yet recruitingThis study looks at whether giving hydrocortisone for one month after adrenal gland removal can slow kidney function decline in patients with primary aldosteronism and chronic kidney disease. About 90 adults will be randomly assigned to receive either hydrocortisone or standard c…
Phase: PHASE4 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New pill could tame Hormone-Driven high blood pressure
Disease control Not yet recruitingThis study tests an experimental drug called QLS1410 for people with primary aldosteronism, a condition where the adrenal glands make too much aldosterone, causing high blood pressure. The trial will compare the drug to a placebo in 60 adults to see if it safely lowers blood pres…
Phase: PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Blood test may end need for risky vein sampling in adrenal hypertension
Diagnosis Not yet recruitingThis study tests whether measuring certain hormones in a blood sample can accurately identify which patients with primary aldosteronism (a common cause of high blood pressure) have a curable adrenal tumor. Currently, diagnosis often requires an invasive procedure called adrenal v…
Phase: NA • Sponsor: Changi General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
Could a common heart drug stop high blood pressure before it starts?
Prevention Not yet recruitingThis trial tests whether eplerenone, a drug that blocks the hormone aldosterone, can prevent the onset of high blood pressure in people aged 30–55 who have a mild, early form of primary aldosteronism but normal blood pressure. Participants will receive either eplerenone or a plac…
Phase: PHASE2, PHASE3 • Sponsor: Xinjiang Medical University • Aim: Prevention
Last updated Jul 29, 2026 00:00 UTC
-
Tiny trial to see if a dye helps adrenal surgery
Knowledge-focused Not yet recruitingThis study will look at 12 people having surgery to remove an adrenal gland (adrenalectomy) using robotic or laparoscopic methods. Some surgeries will use a green dye called Indocyanine Green (ICG) to help the surgeon see better, while others will not. The main goal is to track c…
Sponsor: University of Roma La Sapienza • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Virtual doppelgänger may help pick right patients for kidney nerve treatment
Knowledge-focused Not yet recruitingThis pilot study will test whether a personalized computer model, called a 'digital twin,' can predict which patients with high blood pressure will respond to a procedure called renal denervation. The study will enroll 60 people, including those with resistant hypertension, untre…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC